For example, the above mentioned PI3K inhibitor, LY294002, can inhibit the occurrence and development of ESCC by inhibiting the PI3K/Akt/mTOR/p70S6K signaling pathway. Here, RPS6KB1 is linked to esophageal squamous cell carcinoma.